- Home
- LUCY vs BFRG Comparison
LUCY vs BFRG Comparison
Compare LUCY & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- BFRG
- Stock Information
- Founded
- LUCY 2017
- BFRG 2017
- Country
- LUCY United States
- BFRG United States
- Employees
- LUCY N/A
- BFRG N/A
- Industry
- LUCY Ophthalmic Goods
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- LUCY Health Care
- BFRG Technology
- Exchange
- LUCY Nasdaq
- BFRG Nasdaq
- Market Cap
- LUCY 18.5M
- BFRG 21.2M
- IPO Year
- LUCY 2022
- BFRG 2023
- Fundamental
- Price
- LUCY $6.85
- BFRG $2.28
- Analyst Decision
- LUCY Strong Buy
- BFRG
- Analyst Count
- LUCY 1
- BFRG 0
- Target Price
- LUCY $20.00
- BFRG N/A
- AVG Volume (30 Days)
- LUCY 695.0K
- BFRG 68.4K
- Earning Date
- LUCY 11-12-2024
- BFRG 11-08-2024
- Dividend Yield
- LUCY N/A
- BFRG N/A
- EPS Growth
- LUCY N/A
- BFRG N/A
- EPS
- LUCY N/A
- BFRG N/A
- Revenue
- LUCY $1,561,506.00
- BFRG N/A
- Revenue This Year
- LUCY $245.17
- BFRG N/A
- Revenue Next Year
- LUCY $258.97
- BFRG N/A
- P/E Ratio
- LUCY N/A
- BFRG N/A
- Revenue Growth
- LUCY 158.62
- BFRG 550.00
- 52 Week Low
- LUCY $3.26
- BFRG $1.43
- 52 Week High
- LUCY $27.20
- BFRG $8.35
- Technical
- Relative Strength Index (RSI)
- LUCY 46.42
- BFRG 41.21
- Support Level
- LUCY $6.59
- BFRG $2.18
- Resistance Level
- LUCY $8.80
- BFRG $2.68
- Average True Range (ATR)
- LUCY 0.85
- BFRG 0.19
- MACD
- LUCY -0.09
- BFRG -0.00
- Stochastic Oscillator
- LUCY 6.82
- BFRG 33.33
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.